May 6, 2026 10:20am
On Wednesday following a report that the U.S. and Iran were nearing an agreement to end the war
I'm ... back in the game, a brief hiatus!
Although after catching a tail wind, will head winds help the bomber
Earnings: Sarepta Therapeutics (SRPT) – Wednesday, 5/6
Never leave retail investor uninformed … I say what others won’t, so you can KNOW what others can’t!
Say/write less, mean more …
Little miss of a day and two and a weekend hospital visit – the goldarn Nasdaq gave me an ulcer
I chose to speak-up when many analysts, brokers and commentators have shut-up!
Remember that overnight action in futures don't necessarily translate into actual trading in today’s regular stock market session.
Wednesday: The pre-open Dow futures are UP1% or (505.04 points), the S&P futures are UP +0.78 % (+56.17 points) and the Nasdaq futures are 0.95% or (+240.83 points)
- U.S. stock futures were up <Wednesdaay,5/5
- European equities and bourses soared
- Most major Asian markets hit new highs
Economic Data: It’s still all about oil pricing
- April’ - ADP employment
- 9:30 am St. Lous Fed President Alberto Musalem speech
- 1:00 pm Chicago Fed President Austan Goolsbee speech
\
Q2- May - 1 negative and a 1 positive closess
Q2/26 – May – 2 Positive close
- Q2/26 – April - 1 neutral, 10 negative, 9 positive closes and 1 holiday
- Q1 – March – 9 positive and 13 negative closes
- February – 1 market holiday, 11 positive and 8 negative closes
- January – 2 holiday, 2 neutral, 9 negative and 9 positive closes
Companies in my headlights – It’s your decision; I provide ideas and context
I post about “indication intelligence” looking toward investment conferences … to assist investors with insight into sector vulnerabilities and strengths. A dictionary definition of “indicate” refers to something less than a certainty; an indication could be a signal of being oversold or overbought, a recommendation, or grounds for inferring or a basis for believing.
STILL …Dangerous times re share pricing
The BOTTOM LINE: Welcome to my world of defining the “grey’ in our universe!
Good view of my esofagous, it works"
Q1/26 Earnings Release Dates:
- Sarepta Therapeutics (SRPT) – Wednesday, 5/6
- Vericel (VCEL) – Thursday, 5/7
Welcome to my world of defining the “grey’ in our universe!
- I hate to be so negative or contrarian but, this is a NO spin zone and facts and truth are its products; I can always be WRONG but, I am mostly EARLY!
- if I wanted to be liked, I wouldn’t have been an analyst/journalist.
May 1st week – 1 positive and 1 negative close
As the leading voice of cell and gene therapy investors; I am NOT always a doom and gloom analyst/journalist but a man who has been “there” (BUY, SELL, VC and multiple operating roles) with the gray hair and a readership following with real numbers to prove it!
- I am more frequently right than consequentially wrong; if I wanted to be liked, I wouldn’t have been an analyst/journalist.
Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice. All investments are subject to risks. Investors should consider investment objectives.
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives. Regulation Analyst Certification (Reg AC):
The research analyst primarily responsible for the content of this report certifies the following under Reg AC: I hereby certify that all views expressed in this report accurately reflect my personal views about the subject company or companies and it’s or their securities. I also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed.
